11-Aug-2026 - StockStory.org Amgen’s Q2 earnings call: Our top 5 analyst questions Amgen’s second quarter results reflected broad-based portfolio momentum, with management crediting double-digit growth in key ...
8-Aug-2026 - The Globe and Mail J.P. Morgan Reaffirms Their Hold Rating on Amgen (AMGN) J.P. Morgan analyst Chris Schott maintained a Hold rating on Amgen yesterday and set a price target of $350.00. The company’s shares closed yesterday at $404.85. Unlock powerful investing tools with ...
7-Aug-2026 - CNBC Trade Tracker: Kevin Simpson buys more Amgen Kevin Simpson, Capital Wealth Planning founder and CIO, joins CNBC's 'Halftime Report' to explain why he's buying more Amgen ...
6-Aug-2026 - The Globe and Mail UBS Keeps Their Buy Rating on Amgen (AMGN) In a report released today, Michael Yee from UBS maintained a Buy rating on Amgen, with a price target of $440.00. Claim 55% Off TipRanks. Unlock powerful investing tools with Tip ...
5-Aug-2026 - Seeking Alpha Amgen: First $10 Billion Quarter, More Growth Ahead Amgen Inc. Q2 beat lifts FY guidance despite LOE headwinds; see portfolio drivers, pipeline catalysts, and M&A limits—click ...
5-Aug-2026 - StockStory.org Why Amgen (AMGN) stock is trading up today What Happened? Shares of biotech company Amgen (NASDAQ:AMGN) jumped 3.1% in the afternoon session after the company reported ...
Latest AMGN Trades by Congress Members
5-JUN-2026 - David J. Taylor, OH (District 2) purchased between $1,001 and $15,000.
11-Aug-2026 - StockStory.org Amgen’s Q2 earnings call: Our top 5 analyst questions Amgen’s second quarter results reflected broad-based portfolio momentum, with management crediting double-digit growth in key ...
8-Aug-2026 - The Globe and Mail J.P. Morgan Reaffirms Their Hold Rating on Amgen (AMGN) J.P. Morgan analyst Chris Schott maintained a Hold rating on Amgen yesterday and set a price target of $350.00. The company’s shares closed yesterday at $404.85. Unlock powerful investing tools with ...
7-Aug-2026 - CNBC Trade Tracker: Kevin Simpson buys more Amgen Kevin Simpson, Capital Wealth Planning founder and CIO, joins CNBC's 'Halftime Report' to explain why he's buying more Amgen ...
6-Aug-2026 - The Globe and Mail UBS Keeps Their Buy Rating on Amgen (AMGN) In a report released today, Michael Yee from UBS maintained a Buy rating on Amgen, with a price target of $440.00. Claim 55% Off TipRanks. Unlock powerful investing tools with Tip ...
5-Aug-2026 - Seeking Alpha Amgen: First $10 Billion Quarter, More Growth Ahead Amgen Inc. Q2 beat lifts FY guidance despite LOE headwinds; see portfolio drivers, pipeline catalysts, and M&A limits—click ...
5-Aug-2026 - StockStory.org Why Amgen (AMGN) stock is trading up today What Happened? Shares of biotech company Amgen (NASDAQ:AMGN) jumped 3.1% in the afternoon session after the company reported ...
